Real life retrospective study of cannabidiol therapy in alternating hemiplegia of childhood.

Many alternating hemiplegia of childhood (AHC) patients have received Cannabidiol (CBD) but, to our knowledge, there are no published data available. Test the hypothesis that CBD has favorable effects on AHC spells. Retrospective review of available data of AHC patients who received CBD. Primary analysis: Clinical Global Impression Scale of Improvement (CGI-I) score for response of AHC spells to CBD with calculation of 95% confidence interval (CI) for rejection of the null hypothesis. Secondary analyses, performed to achieve an understanding of the effect of CBD as compared to flunarizine, were CGI-I scores of 1) epileptic seizures to CBD, 2) AHC spells to flunarizine, 3) epileptic seizures to flunarizine. Also, Mann-Whitney test was done for comparison of CGI-I scores of CBD and flunarizine to both AHC spells and seizures. We studied 16 AHC patients seen at Duke University and University of Lyon. CI of CGI-I scores for AHC spells in response to CBD and to flunarizine, each separately, indicated a positive response to each of these two medications: neither overlapped with the null hypothesis score, 4, indicating significant positive responses with p < 0.05 for both. These two scores also did not differ (p = 0.84) suggesting similar efficacy of both: CBD score was 2 ± 1.1 with a 95% CI of 1.5–2.6 and flunarizine score was 2.3 ± 1.3 with a 95% CI of 1.7–3.1. In patients who had seizures, CI calculations indicated a positive effect of CBD on seizure CGI scores but not of flunarizine on seizure scores. CBD was well tolerated with no patients discontinuing it due to side effects and with some reporting positive behavioral changes. Our study indicates a real-life positive effect of CBD on AHC type spells. • Real life study of 16 Alternating Hemiplegia of Childhood (AHC) patients • Response of AHC spells to cannabidiol was assessed • We determined the Clinical Global Impression Scale of Improvement scores • Scores showed significant response and cannabidiol was well tolerated [ABSTRACT FROM AUTHOR]